Form 4: Neogenomics Director Lynn A. Tetrault Sells Shares
SEC Form 4 Filing
Director Lynn A. Tetrault sold 6,112 shares of Neogenomics Inc. on March 4, 2024, at a price of $15.9651 per share.
Summary
- On March 4, 2024, Lynn A. Tetrault, a director of Neogenomics Inc., sold 6,112 shares of common stock at a price of $15.9651 per share.
- Following the transaction, Tetrault directly owns 50,062 shares of Neogenomics Inc.
- Tetrault also holds various stock options and restricted stock units.
Sentiment
Score: 4
Explanation: The sentiment is neutral to slightly negative. While the filing itself is a standard disclosure, the sale of shares by a director can sometimes be interpreted negatively by investors.
Negatives
- A director selling shares could be perceived negatively by investors.
Risks
- The sale of shares by a director could indicate a lack of confidence in the company's future performance, although this is not necessarily the case.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common in publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company's prospects.
Stakeholder Impact
- Shareholders may react to the director's sale of shares, potentially impacting the stock price.
Key Dates
| Date | Description |
|---|---|
| 06/06/2020 | Date of grant for stock options expiring on 06/06/2026 with an exercise price of $22.52. |
| 05/28/2021 | Date of grant for stock options expiring on 05/28/2027 with an exercise price of $28.54. |
| 06/02/2022 | Date of grant for stock options expiring on 06/02/2028 with an exercise price of $40.9. |
| 10/11/2022 | Date of grant for stock options expiring on 10/11/2028 with an exercise price of $41.76. |
| 06/10/2023 | Date of grant for stock options expiring on 06/10/2029 with an exercise price of $8.1. |
| 03/04/2024 | Date of the transaction where Lynn A. Tetrault sold 6,112 shares of common stock. |
| 08/10/2024 | Date of grant for stock options expiring on 08/10/2033 with an exercise price of $14.82 and vesting date for restricted stock units. |
| 06/06/2026 | Expiration date for stock options with an exercise price of $22.52. |
| 05/28/2027 | Expiration date for stock options with an exercise price of $28.54. |
| 06/02/2028 | Expiration date for stock options with an exercise price of $40.9. |
| 10/11/2028 | Expiration date for stock options with an exercise price of $41.76. |
| 06/10/2029 | Expiration date for stock options with an exercise price of $8.1. |
| 08/10/2033 | Expiration date for stock options with an exercise price of $14.82. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.